EP Patent

EP0481214B1 — Prodrugs of phosphonates

Assigned to Institute Of Organic Chemistry And Biochemistry Of · Expires 1998-06-24 · 28y expired

What this patent protects

There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor…

USPTO Abstract

There are disclosed novel oral prodrugs of phosphonate nucleotide analogs which are hydrolyzable under physiological conditions to yield compounds which are useful as antiviral agents, especially as agents effective against RNA and DNA viruses. They may also find use as antitumor agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0481214B1
Jurisdiction
EP
Classification
—
Expires
1998-06-24
Drug substance claim
No
Drug product claim
No
Assignee
Institute Of Organic Chemistry And Biochemistry Of
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.